# Retrospective Multicenter Real-world Observational Study of Switching to Aflibercept 8 mg in Patients With Refractory or Dependent Exudative Age-related Macular Degeneration

> **NCT07423429** · — · NOT_YET_RECRUITING · sponsor: **Nantes University Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Exudative Age-Related Macular Degeneration

## Interventions

- **DRUG:** aflibercept 8 mg

## Key facts

- **NCT ID:** NCT07423429
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07423429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07423429, "Retrospective Multicenter Real-world Observational Study of Switching to Aflibercept 8 mg in Patients With Refractory or Dependent Exudative Age-related Macular Degeneration". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07423429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*